Moreover, the expression levels of FOXD3-AS1 show a close association with clinicopathological features, such as tumor size, grade, poor differentiation, lymph node metastasis, distant metastasis, overall survival and progression-free survival, which might be available for predicting the prognosis of patients. This evidence concerns the gene FOXD3 and metastatic malignant neoplasm in the lymph nodes.